Novavax coronavirus vaccine induces immune response in early study, shares jump

Novavax Inc said on Tuesday its experimental COVID19 vaccine produced high levels of antibodies against the novel coronavirus, according to initial data from a small, earlystage clinical trial, sending the company's shares up 10%.

from Top Business News- News18.com
via IFTTT